Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ignyta
Biotech
Boundless Bio uncloaks with $46M to pursue extrachromosomal DN
With $46 million, Boundless is using a new understanding of amplification mutatons to create a new class of drugs to fight difficult-to-treat cancers.
Amirah Al Idrus
Sep 19, 2019 5:00am
Erasca picks up $42M to target biological drivers of cancer
Dec 18, 2018 9:28am
Roche splashes $1.7B in cash for Ignyta and entrectinib
Dec 22, 2017 4:21am
Ignyta NSCLC durability data set stage for Pfizer fight
Oct 18, 2017 9:26am
ROS1 cancer patients set out to create disease models
Aug 15, 2017 8:55am
Ignyta agrees new terms with Lilly for troubled cancer alliance
Mar 24, 2017 9:29am